Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
1.093,811.096,521.100,221.091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
1.254,811.253,011.253,871.226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
1.761,111.764,271.766,881.744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
3.211,833.227,213.268,383.226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
1.474,521.479,031.481,041.466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
2.392,122.396,952.421,222.382,32
Q1 2026 earnings • released • EPS beat +12,21% • Revenue beat +0,83%
See results
ZBH:NYSE
Zimmer Biomet Holdings, Inc
82,90 US$
+0,57%
(+0,47) 1D
82,90 US$
0,00% (0,00)
After hours
Closed: 1 may, 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZBH...
Açın
82,76 US$
High
84,01 US$
Low
82,16 US$
Mkt. cap
16,05 mlrd
Volume
2,72 mln
Dividend
1,16%
Quarterly dividend
0,24 US$
Ex dividend date
31 mar 2026
P/E ratio
21,53
52-wk high
108,29 US$
52-wk low
79,83 US$
EPS
3,85 US$
Beta
0,61
Shares outstanding
193,57 mln
No. of employees
17K
News stories
From sources across the web
Profile
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook. Wikipedia
About Zimmer Biomet Holdings, Inc
CEOIvan Tornos
Employees17K
Founded1927
HeadquartersWarsaw, İndiana, Amerika Birləşmiş Ştatları
SectorMedical device
Last report
28 apr 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
2,09/ (1,86 est.)USD
+12,21%beat
Revenue / Estimate
2,09 mlrd/ (2,07 mlrd est.)USD
+0,83%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
iyn 2025
sen 2025
dek 2025
mar 2026
Revenue
2,08 mlrd
2,00 mlrd
2,24 mlrd
2,09 mlrd
Cost of goods sold
590,70 mln
559,30 mln
795,50 mln
562,90 mln
Cost of revenue
590,70 mln
559,30 mln
795,50 mln
562,90 mln
Research and development expenses
113,30 mln
115,90 mln
118,70 mln
103,40 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
807,20 mln
809,40 mln
838,50 mln
849,90 mln
Operating expense
1,08 mlrd
1,10 mlrd
1,13 mlrd
1,12 mlrd
Total operating expenses
1,67 mlrd
1,66 mlrd
1,93 mlrd
1,68 mlrd
Operating income
405,50 mln
340,30 mln
313,40 mln
408,40 mln
Other non operating income
3,60 mln
6,20 mln
15,10 mln
-3,10 mln
EBT including unusual items
224,60 mln
279,20 mln
97,90 mln
301,30 mln
EBT excluding unusual items
327,80 mln
269,30 mln
250,00 mln
336,50 mln
Income tax expense
71,20 mln
48,00 mln
-39,90 mln
63,00 mln
Effective tax rate
31,70%
17,19%
-40,76%
20,91%
Other operating expenses
-
-
-
-
Net income
152,80 mln
230,90 mln
139,30 mln
238,10 mln
Net profit margin
7,36%
11,54%
6,21%
11,41%
Earnings per share
2,07
1,90
2,42
2,09
Interest and investment income
-
-
-
-
Interest expense
-79,30 mln
-75,40 mln
-71,90 mln
-68,80 mln
Net interest expenses
-79,30 mln
-75,40 mln
-71,90 mln
-68,80 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
677,30 mln
623,90 mln
597,40 mln
678,40 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more